This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassemia. Lancet. 2012; 379:373-83.10.1016/S0140-6736(11)60283-321908035HiggsDREngelJDStamatoyannopoulosG.ThalassemiaLancet.201237937383Open DOISearch in Google Scholar
Greenberg PL, Gordeuk V, Issaragrisil S, Siritanaratkul N, Fucharoen S, Ribeiro RC. Major hematologic diseases in the developing world—new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology Am Soc Hematol Educ Program. 2001:479-98.11723000GreenbergPLGordeukVIssaragrisilSSiritanaratkulNFucharoenSRibeiroRC.Major hematologic diseases in the developing world—new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemiaHematology Am Soc Hematol Educ Program.20014799810.1182/asheducation-2001.1.47911723000Search in Google Scholar
Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89:1187-93.15477202Borgna-PignattiCRugolottoSDe StefanoPZhaoHCappelliniMDDel VecchioGCSurvival and complications in patients with thalassemia major treated with transfusion and deferoxamineHaematologica.200489118793Search in Google Scholar
Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005; 1054:40-7.10.1196/annals.1345.00616339650Borgna-PignattiCCappelliniMDDe StefanoPDel VecchioGCForniGLGamberiniMRSurvival and complications in thalassemiaAnn N Y Acad Sci.2005105440716339650Open DOISearch in Google Scholar
Di Bartolomeo P, Santarone S, Di Bartolomeo E, Olioso P, Bavaro P, Papalinetti G, et al. Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol. 2008; 83:528-30.10.1002/ajh.2117518383328Di BartolomeoPSantaroneSDi BartolomeoEOliosoPBavaroPPapalinettiGLong-term results of survival in patients with thalassemia major treated with bone marrow transplantationAm J Hematol.2008835283018383328Open DOISearch in Google Scholar
Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, et al. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies. Blood Cells Mol Dis. 2009; 42:247-51.10.1016/j.bcmd.2009.01.00219233692MaggioAVitranoACapraMCucciaLGagliardottoFFilosaAImproving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and HemoglobinopathiesBlood Cells Mol Dis.2009422475119233692Open DOISearch in Google Scholar
Nakhakes C, Jaruluxananan S, Saengsuda Y, Saengsuda S. Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospital. Asian Biomed. 2015; 8:169-74.NakhakesCJaruluxanananSSaengsudaYSaengsudaS.Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospitalAsian Biomed.201581697410.5372/1905-7415.0902.383Search in Google Scholar
Siripunthana S, Sahakitrungruang T, Wacharasindhu S, Sosothikul D, Supornsilchai V. Testicular function in patients with regular blood transfusion for thalassemia major. Asian Biomed. 2015; 8:185-91.SiripunthanaSSahakitrungruangTWacharasindhuSSosothikulDSupornsilchaiV.Testicular function in patients with regular blood transfusion for thalassemia majorAsian Biomed.201581859110.5372/1905-7415.0902.385Search in Google Scholar
Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010; 115:1886-92.10.1182/blood-2009-09-24315420032507TaherATMusallamKMKarimiMEl-BeshlawyABelhoulKDaarSOverview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE studyBlood.201011518869220032507Open DOISearch in Google Scholar
Al-Rimawi HS, Jallad MF, Amarin ZO, Al Sakaan R. Pubertal evaluation of adolescent boys with β-thalassemia major and delayed puberty. Fertil Steril. 2006; 86:886-90.10.1016/j.fertnstert.2006.02.11817027358Al-RimawiHSJalladMFAmarinZOAl SakaanR.Pubertal evaluation of adolescent boys with β-thalassemia major and delayed pubertyFertil Steril.2006868869017027358Open DOISearch in Google Scholar
De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006; 19:471-80.16759032De SanctisVRoosMGasserTFortiniMRaiolaGGalatiMC.Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemiaJ Pediatr Endocrinol Metab.20061947180Search in Google Scholar
Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia. J Pediatr Hematol Oncol. 2003; 25:880-4.10.1097/00043426-200311000-0001114608198ChernJPLinKHTsaiWYWangSCLuMYLinDTHypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemiaJ Pediatr Hematol Oncol.200325880414608198Open DOISearch in Google Scholar
Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica. 1995; 80:58-68.7758995CamaschellaCCappelliniMD.Thalassemia intermediaHaematologica.1995805868Search in Google Scholar
Musallam KM, Taher AT, Rachmilewitz EA. β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012; 2:a013482.22762026MusallamKMTaherATRachmilewitzEA.β-thalassemia intermedia: a clinical perspectiveCold Spring Harb Perspect Med.20122a01348210.1101/cshperspect.a013482338594322762026Search in Google Scholar
Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37: 12-20.10.1016/j.bcmd.2006.04.00516737833TaherAIsma’eelHCappelliniMD.Thalassemia intermedia: revisitedBlood Cells Mol Dis200637122016737833Open DOISearch in Google Scholar
Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed. 2007; 1:1-6.FucharoenSWinichagoonP.Prevention and control of thalassemia in AsiaAsian Biomed.2007116Search in Google Scholar
Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013; 3:a011775.23378598CaoAKanYW.The prevention of thalassemiaCold Spring Harb Perspect Med.20133a01177510.1101/cshperspect.a011775355234523378598Search in Google Scholar
